JuanCJaumeMD

Diabetes, Lipid Metabolism

Assistant Professor, Medicine, University of Wisconsin Medical School

Are you Dr. Jaume?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
You already have 35 invites waiting!
Read the latest clinical news, personalized to your specialty.

Office
2100 W Central Ave
Fl 2
Toledo, OH 43606
Phone+1 567-420-1600

Fax+1 567-420-1633

Dr. Juan Jaume, MD is an endocrinologist in Toledo, Ohio. He is currently licensed to practice medicine in Ohio, Wisconsin, and California. He is affiliated with ProMedica Toledo Hospital and The University of Toledo Medical Center.

University of California (San Francisco)Fellowship, Endocrinology, Diabetes, and Metabolism, 1991 - 1994
Zucker School of Medicine at Hofstra/NorthwellResidency, Internal Medicine, 1988 - 1991
Zucker School of Medicine at Hofstra/NorthwellInternship, Transitional Year, 1987 - 1988
University of Buenos AiresClass of 1985

PubMed

Intense Testing and Use of Vitamin D Supplements Leads to Slow Improvement in Vitamin D Adequacy Rates: A Cross-Sectional Analysis of Real-World Data.
Rodis D Paparodis, Dimitra Bantouna, Evangelos Karvounis, Ioannis Zoupas, Sarantis Livadas
Nutrients. 2023-12-28
1 citations
Elevated Preoperative TPO Ab Titers Decrease Risk for DTC in a Linear Fashion: A Retrospective Analysis of 1635 Cases.
Rodis Paparodis, Sarantis Livadas, Evangelos Karvounis, Dimitra Bantouna, Ioannis Zoupas
The Journal of Clinical Endocrinology and Metabolism. 2023-12-21
Efficacy and Safety of Insulin Icodec Versus Glargine U100: A Meta-Analysis of Randomized Controlled Trials.
Kirubel Zerihun, Mohammed Mhanna, Hazem Ayesh, Sami Ghazaleh, Yasmin Khader
American Journal of Therapeutics. 2022-08-22

Researchers Develop Pancreatic Beta-Cell Restoring Therapy for Treating Type 1 DiabetesJune 13th, 2022
A Lifesaver with a Catch: Powerful New Cancer Drugs Can Trigger Diabetes — and No One Is Certain WhyMay 29th, 2019
A New Mouse Model May Unlock the Secrets of Type I DiabetesFebruary 12th, 2019

An Animal Model For Graves'Disease/OphthalmologyNational Eye Institute2004–2005
Antigen Specific Immunity In Type 1 DiabetesNational Institute Of Diabetes And Digestive And Kidney Diseases2003–2005
Antigen Specific Immunity In Type 1 DiabetesNational Institute Of Diabetes And Digestive And Kidney Diseases2003
An Animal Model For Graves'Disease/OphthalmopathyNational Eye Institute2003
Ophthalmopathy Of Graves DiseaseNational Eye Institute1997–2001